Tom Cech

First Person | Tom Cech Courtesy of Paul Fetters, HHMI Tom Cech, 55, president of the Howard Hughes Medical Institute, understands that luck has graced his life. He skipped the "What-should-I-do-with-my-life" angst, knowing since grade school that he wanted to be a scientist. And when he mixed ammonia and bleach in his own little lab in his parents' basement, no life or property was lost. He met his lifelong partner, Carol, in an organic chemistry class at Grinnell College in Iowa. After

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Tom Cech, 55, president of the Howard Hughes Medical Institute, understands that luck has graced his life. He skipped the "What-should-I-do-with-my-life" angst, knowing since grade school that he wanted to be a scientist. And when he mixed ammonia and bleach in his own little lab in his parents' basement, no life or property was lost.

He met his lifelong partner, Carol, in an organic chemistry class at Grinnell College in Iowa. After doing their postdocs in Boston (his at Massachusetts Institute of Technology, hers at Harvard University), they moved to the University of Colorado. And there, while working on how chromatin structure affects transcription, Cech and company found an excised intron while looking at the RNA. They abandoned chromatin structure and followed that intron, leading, eventually to identifying RNA as a biocatalyst, and to the Nobel Prize. Says Cech: "It's good intuition and some luck, and that certainly helped us ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies